OREKA CARE: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
OREKA CARE
Largest movements
- Stocks and contracts +€6,265
new in 2024: €6,265
- Cash -€1,039
down €1,039 (-79.6%), from €1,305 to €266
mainly Stocks and contracts (-€6,265) and Trade debts (-€2,700)
- Financial fixed assets +€600
up €600 (+261%), from €230 to €830
- Receivables within one year -€396
down €396 (-86.9%), from €456 to €60
of which Other amounts receivable: -€286
- Profit (loss) carried forward +€3,681
up €3,681 (+30.3%), from -€12,139 to -€8,458
- Other debts +€3,543
up €3,543 (+230%), from €1,542 to €5,085
- Trade debts -€2,700
no longer reported in 2024 (was €2,700)
- Tax, wage and social debts +€906
new in 2024: €906
- Gross operating margin +€16,683
up €16,683, from -€11,958 to €4,725
- Other operating charges +€702
up €702 (+382%), from €184 to €886
- Financial charges +€137
up €137 (+651%), from €21 to €158
From the 2023 result to the 2024 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2023 and 2024 balance sheets and the 2024 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2023 | 2024 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €2,103 | €7,533 | +€5,430 | +258% |
| Fixed assets | 21/28 | €230 | €830 | +€600 | +261% |
| Financial fixed assets | 28 | €230 | €830 | +€600 | +261% |
| Current assets | 29/58 | €1,873 | €6,703 | +€4,830 | +258% |
| Stocks and contracts in progress | 3 | - | €6,265 | +€6,265 | |
| Stocks | 30/36 | - | €6,265 | +€6,265 | |
| Amounts receivable within one year | 40/41 | €456 | €60 | -€396 | -86.9% |
| Trade receivables | 40 | €170 | €60 | -€110 | -64.8% |
| Other amounts receivable | 41 | €286 | - | -€286 | |
| Cash at bank and in hand | 54/58 | €1,305 | €266 | -€1,039 | -79.6% |
| Deferred charges and accrued income | 490/1 | €112 | €112 | = | 0.0% |
| Total equity and liabilities | 10/49 | €2,103 | €7,533 | +€5,430 | +258% |
| Equity | 10/15 | -€2,139 | €1,542 | +€3,681 | |
| Contributions | 10/11 | €10,000 | €10,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€12,139 | -€8,458 | +€3,681 | +30.3% |
| Amounts payable | 17/49 | €4,242 | €5,991 | +€1,749 | +41.2% |
| Amounts payable within one year | 42/48 | €4,242 | €5,991 | +€1,749 | +41.2% |
| Trade debts | 44 | €2,700 | - | -€2,700 | |
| Suppliers | 440/4 | €2,700 | - | -€2,700 | |
| Taxes, remuneration and social security | 45 | - | €906 | +€906 | |
| Taxes | 450/3 | - | €906 | +€906 | |
| Other amounts payable | 47/48 | €1,542 | €5,085 | +€3,543 | +230% |
| Other operating charges | 640/8 | €184 | €886 | +€702 | +382% |
| Gross operating margin | 9900 | -€11,958 | €4,725 | +€16,683 | |
| Operating profit (loss) | 9901 | -€12,142 | €3,838 | +€15,981 | |
| Financial income | 75/76B | €25 | €0 | -€25 | -99.9% |
| Recurring financial income | 75 | €25 | €0 | -€25 | -99.9% |
| Financial charges | 65/66B | €21 | €158 | +€137 | +651% |
| Recurring financial charges | 65 | €21 | €158 | +€137 | +651% |
| Profit (loss) for the period before taxes | 9903 | -€12,139 | €3,681 | +€15,819 | |
| Profit (loss) for the period | 9904 | -€12,139 | €3,681 | +€15,819 | |
| Profit (loss) for the period to be appropriated | 9905 | -€12,139 | €3,681 | +€15,819 |
Source: filed annual accounts (NBB), financial years ended 31 December 2023 and 31 December 2024. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 22 October 2026 via checked.be.